Insider · CIK 0001748691

Kaye Mark

Reports to the SEC for 3 companies · INDIANAPOLIS, IN

sec.gov

Transactions

Companies

Filings

CIK

0001748691

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-22	ELVElevance Health, Inc.S Sale	EVP & CFO	SSale	−273 sh	$447.19	−$122K	19,919
2026-10-22	ELVElevance Health, Inc.S Sale	EVP & CFO	SSale	−827 sh	$446.05	−$369K	20,192
2026-10-22	ELVElevance Health, Inc.S Sale	EVP & CFO	SSale	−160 sh	$444.85	−$71.2K	21,019
2026-10-22	ELVElevance Health, Inc.S Sale	EVP & CFO	SSale	−440 sh	$443.81	−$195K	21,179
2026-10-22	ELVElevance Health, Inc.S Sale	EVP & CFO	SSale	−480 sh	$442.61	−$212K	21,619
2026-10-22	ELVElevance Health, Inc.S Sale	EVP & CFO	SSale	−2,343 sh	$441.34	−$1.03M	22,099
2026-10-22	ELVElevance Health, Inc.S Sale	EVP & CFO	SSale	−1,720 sh	$440.44	−$758K	24,442
2026-10-22	ELVElevance Health, Inc.S Sale	EVP & CFO	SSale	−1,160 sh	$439.25	−$510K	26,162
2026-10-22	ELVElevance Health, Inc.S Sale	EVP & CFO	SSale	−240 sh	$438.22	−$105K	27,322
2026-10-22	ELVElevance Health, Inc.S Sale	EVP & CFO	SSale	−560 sh	$437.07	−$245K	27,562
2026-10-22	ELVElevance Health, Inc.S Sale	EVP & CFO	SSale	−1,660 sh	$436.20	−$724K	28,122
2026-10-22	ELVElevance Health, Inc.S Sale	EVP & CFO	SSale	−321 sh	$435.25	−$140K	29,782
2026-10-22	ELVElevance Health, Inc.S Sale	EVP & CFO	SSale	−400 sh	$434.00	−$174K	30,103
2026-10-02	ELVElevance Health, Inc.F Tax Payment	EVP & CFO	FTax Payment	−4,161 sh	$386.43	−$1.61M	27,876
2026-10-02	ELVElevance Health, Inc.A Award	EVP & CFO	AAward	+2,627 sh	—	—	30,503
2026-06-02	CNMDCONMED CorpM Exercise/Conversion	Director	MExercise/Conversion	+668 sh	—	—	820
2026-06-02	CNMDCONMED Corp · RSUs (Restricted Stock Units)M Exercise/Conversion	Director	MExercise/Conversion	−668 sh	—	—	0
2026-06-01	CNMDCONMED Corp · RSUs (Restricted Stock Units)A Award	Director	AAward	+5,772 sh	—	—	5,772
2026-03-03	ELVElevance Health, Inc.F Tax Payment	EVP & CFO	FTax Payment	−353 sh	$284.03	−$100K	32,037
2026-03-02	ELVElevance Health, Inc.F Tax Payment	EVP & CFO	FTax Payment	−271 sh	$294.07	−$79.7K	15,811
2026-03-02	ELVElevance Health, Inc.A Award	EVP & CFO	AAward	+6,377 sh	—	—	22,188
2026-03-02	ELVElevance Health, Inc.A Award	EVP & CFO	AAward	+10.2K sh	—	—	32,390
2026-03-02	ELVElevance Health, Inc. · Employee Stock Option (Right to Buy)A Award	EVP & CFO	AAward	+25.2K sh	—	—	25,188
2026-02-24	CNMDCONMED CorpM Exercise/Conversion	Director	MExercise/Conversion	+152 sh	—	—	152
2026-02-24	CNMDCONMED Corp · RSUs (Restricted Stock Units)M Exercise/Conversion	Director	MExercise/Conversion	−152 sh	—	—	0
2025-10-02	ELVElevance Health, Inc.F Tax Payment	EVP & CFO	FTax Payment	−2,895 sh	$340.24	−$985K	16,082
2025-06-02	CNMDCONMED Corp · Options To Purchase Common StockA Award	Director	AAward	+8,061 sh	—	—	8,061
2025-06-02	CNMDCONMED Corp · RSUs (Restricted Stock Units)A Award	Director	AAward	+668 sh	—	—	668
2025-04-24	ELVElevance Health, Inc.S Sale	EVP & CFO	SSale	−4,588 sh	$424.82	−$1.95M	18,977
2025-03-03	ELVElevance Health, Inc.F Tax Payment	EVP & CFO	FTax Payment	−270 sh	$395.50	−$107K	19,961
2025-03-03	ELVElevance Health, Inc.A Award	EVP & CFO	AAward	+3,604 sh	—	—	23,565
2025-03-03	ELVElevance Health, Inc. · Employee Stock Option (Right to Buy)A Award	EVP & CFO	AAward	+13.7K sh	—	—	13,713
2025-02-24	CNMDCONMED Corp · Options To Purchase Common StockA Award	Director	AAward	+1,846 sh	—	—	1,846
2025-02-24	CNMDCONMED Corp · RSUs (Restricted Stock Units)A Award	Director	AAward	+152 sh	—	—	152
2024-10-02	ELVElevance Health, Inc.F Tax Payment	EVP & CFO	FTax Payment	−2,818 sh	$505.16	−$1.42M	20,213
2024-03-01	ELVElevance Health, Inc.A Award	EVP & CFO	AAward	+2,755 sh	—	—	23,031
2024-03-01	ELVElevance Health, Inc. · Employee Stock Option (Right to Buy)A Award	EVP & CFO	AAward	+10.6K sh	—	—	10,633
2023-10-02	ELVElevance Health, Inc.A Award	EVP & CFO	AAward	+18.2K sh	—	—	18,174
2023-10-02	ELVElevance Health, Inc.A Award	EVP & CFO	AAward	+2,102 sh	—	—	20,276
2023-10-02	ELVElevance Health, Inc. · Employee Stock Option (Right to Buy)A Award	EVP & CFO	AAward	+8,076 sh	—	—	8,076
2023-08-07	MCOMOODYS CORP /DE/S Sale	EVP & Chief Financial Officer	SSale	−3,832 sh	$341.10	−$1.31M	4,447
2023-08-07	MCOMOODYS CORP /DE/M Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	+1,741 sh	$173.58	+$302K	6,188
2023-08-07	MCOMOODYS CORP /DE/S Sale	EVP & Chief Financial Officer	SSale	−1,741 sh	$341.22	−$594K	4,447
2023-08-07	MCOMOODYS CORP /DE/M Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	+3,470 sh	$280.42	+$973K	7,917
2023-08-07	MCOMOODYS CORP /DE/S Sale	EVP & Chief Financial Officer	SSale	−3,470 sh	$340.88	−$1.18M	4,447
2023-08-07	MCOMOODYS CORP /DE/M Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	+714 sh	$277.05	+$198K	5,161
2023-08-07	MCOMOODYS CORP /DE/S Sale	EVP & Chief Financial Officer	SSale	−714 sh	$341.04	−$244K	4,447
2023-08-07	MCOMOODYS CORP /DE/M Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	+3,857 sh	$276.84	+$1.07M	8,304
2023-08-07	MCOMOODYS CORP /DE/S Sale	EVP & Chief Financial Officer	SSale	−3,857 sh	$340.81	−$1.31M	4,447
2023-08-07	MCOMOODYS CORP /DE/M Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	+1,544 sh	$325.99	+$503K	5,991

Recent filings

Accepted (ET)
Oct 234
Kaye Mark0001748691-26-000008
SEC(opens sec.gov)
Oct 64
Kaye Mark0001748691-26-000005
SEC(opens sec.gov)
Jun 34
Kaye Mark0000816956-26-000067
SEC(opens sec.gov)
Mar 44
Kaye Mark0001748691-26-000002
SEC(opens sec.gov)

Companies

Address

220 VIRGINIA AVENUE

INDIANAPOLIS, IN, 46204